Abstract
Over 90% of craniopharyngeal brain tumors are cystic, which enables the injection of beta emitters such as phosphorus-32 (32P) radio-colloid into cysts for their treatment. The aim of this study was to evaluate the clinical and theoretical modelling of Bremsstrahlung radiation dose resulting from stereotactic radio-colloid therapy of cystic craniopharyngioma tumors with 32P. 32P radio-colloid with appropriate activity concentration was injected to a head phantom, and then the Bremsstrahlung radiation spectrum and planar images were obtained using a gamma camera. Both phantom and gamma camera were simulated using MCNPX code, and the results were compared with practical results. Bremsstrahlung radiation spectrum was measured using a handheld gamma spectrometer for two patients treated with stereotactic radio-colloid therapy with 32P in different positions and compared to Monte Carlo simulation. Results of counting and determining sensitivity coefficients in the air and the attenuating environment were obtained. Also, comparing the counting sensitivity from practical and simulation methods indicated the agreement of the data between the two methods. Comparison of the spectra from different positions around patient’s head indicated the ability to use this detector to quantify the activity in the operating room. Selection of the spectrum is important in Bremsstrahlung radiation imaging. We can take advantage of spectrometry measurement using gamma camera, handheld gamma spectrometer for patient, and theoretical modeling with Monte Carlo code to evaluate radiopharmaceutical distribution, leakage, as well as estimate activity and predict therapeutic effects in other adjacent structures and ultimately optimize radio-colloid therapy in cystic craniopharyngeal patients.
Similar content being viewed by others
References
Leksell L, Liden K (1952) A therapeutic trial with radioactive isotopes in cystic brain tumor. Radioisotope Tech 1:1–4
Cabezudo JM, Vaquero J, Areitio E, Martinez R, de Sola RG, Bravo G (1981) Craniopharyngiomas: a critical approach to treatment. J Neurosurg 55(3):371–375. https://doi.org/10.3171/jns.1981.55.3.0371
Karnaze MG, Sartor K, Winthrop JD, Gado MH, Hodges FJ 3rd (1986) Suprasellar lesions: evaluation with MR imaging. Radiology 161(1):77–82. https://doi.org/10.1148/radiology.161.1.3763887
Cohen ME, Duffner PK (1984) Brain tumors in children: principles of diagnosis and treatment. Wiley, Hoboken
Hasegawa T, Kondziolka D, Hadjipanayis CG, Lunsford LD (2004) Management of cystic craniopharyngiomas with phosphorus-32 intracavitary irradiation. Neurosurgery 54(4):813–820 (discussion 820–812)
Voges J, Sturm V, Lehrke R, Treuer H, Gauss C, Berthold F (1997) Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery 40(2):263–269 (discussion 269–270)
Sadeghi M, Karimi E, Hosseini SH (2009) Dosimetric comparison of Y90, P32, and Re186 radiocolloids in craniopharyngioma treatments. Med Phys 36(11):5022–5026. https://doi.org/10.1118/1.3243085
Sadeghi M, Moradi S, Shahzadi S, Pourbeigi H (2007) Dosimetry of (32)P radiocolloid for treatment of cystic craniopharyngioma. Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture. Ind Med 65(5):519–523. https://doi.org/10.1016/j.apradiso.2007.01.018
Treuer H, Hoevels M, Luyken K, Gierich A, Hellerbach A, Lachtermann B, Visser-Vandewalle V, Ruge M, Wirths J (2015) Voxel-based dose calculation in radiocolloid therapy of cystic craniopharyngiomas. Phys Med Biol 60(3):1159–1170. https://doi.org/10.1088/0031-9155/60/3/1159
Azimi P, Shahzadi S, Montazeri A (2016) Outcomes of phosphorus-32 intracavitary irradiation for craniopharyngiomas: a review of the literature. Int Clin Neurosci J 3(1):7–24
Kickingereder P, Maarouf M, El Majdoub F, Fuetsch M, Lehrke R, Wirths J, Luyken K, Schomaecker K, Treuer H, Voges J, Sturm V (2012) Intracavitary brachytherapy using stereotactically applied phosphorus-32 colloid for treatment of cystic craniopharyngiomas in 53 patients. J Neurooncol 109(2):365–374. https://doi.org/10.1007/s11060-012-0902-8
Rojas EL, Al-Dweri FM, Lallena AM, Bodineau C, Galan P (2003) Dosimetry for radiocolloid therapy of cystic craniopharyngiomas. Med Phys 30(9):2482–2492. https://doi.org/10.1118/1.1599653
Bé M, Chisté V, Dulieu C, Browne E, Baglin C, Chechev V, Kuzmenco N, Helmer R, Kondev F, MacMahon D (2006) Table of radionuclides. Monographie BIPM 5 3-A:3–244
Kobayashi T, Kageyama N, Ohara K (1981) Internal irradiation for cystic craniopharyngioma. J Neurosurg 55(6):896–903. https://doi.org/10.3171/jns.1981.55.6.0896
Janicki C, Seuntjens J (2003) Re-evaluation of the dose to the cyst wall in P-32 radiocolloid treatments of cystic brain tumors using the dose-point-kernel and Monte Carlo methods. Med Phys 30(9):2475–2481. https://doi.org/10.1118/1.1599652
Sadeghi M, Karimi E, Sardari D (2009) Monte Carlo and analytical calculations of dose distributions in craniopharyngioma cysts treated with radiocolloids containing 32P or 186Re. Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture. Ind Med 67(9):1697–1701. https://doi.org/10.1016/j.apradiso.2009.03.001
Zhao R, Deng J, Liang X, Zeng J, Chen X, Wang J (2010) Treatment of cystic craniopharyngioma with phosphorus-32 intracavitary irradiation. Child’s Nerv Syst 26(5):669–674. https://doi.org/10.1007/s00381-009-1025-1
Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, Robertson JS, Howell RW, Wessels BW, Fisher DR, Weber DA, Brill AB (1999) MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med 40(2):37s–61s
Hendricks JS, McKinney GW, Fensin ML, James MR, Johns RC, Durkee JW, Finch JP, Pelowitz DB, Waters LS, Johnson MW (2008) MCNPX 2.6. 0 extensions. Los Alamos National Laboratory, New Mexico
Fabbri C, Sarti G, Cremonesi M, Ferrari M, Di Dia A, Agostini M, Botta F, Paganelli G (2009) Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry. Cancer Biother Radiopharm 24(1):145–154. https://doi.org/10.1089/cbr.2008.0543
Lafay-Cousin L, Bartels U, Raybaud C, Kulkarni AV, Guger S, Huang A, Bouffet E (2007) Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. Report of three cases. J Neurosurg 107(4 Suppl):318–323. https://doi.org/10.3171/ped-07/10/318
Barriger RB, Chang A, Lo SS, Timmerman RD, DesRosiers C, Boaz JC, Fakiris AJ (2011) Phosphorus-32 therapy for cystic craniopharyngiomas. Radiother Oncol 98(2):207–212. https://doi.org/10.1016/j.radonc.2010.12.001
Schefter JK, Allen G, Cmelak AJ, Johnson M, Toms S, Duggan D, Blevins LS (2002) The utility of external beam radiation and intracystic 32P radiation in the treatment of craniopharyngiomas. J Neurooncol 56(1):69–78
Shahzadi S, Sharifi G, Andalibi R, Zali A, Ali-Asgari A (2008) Management of cystic craniopharyngiomas with intracavitary irradiation with 32P. Arch Iran Med 11(1):30–34
Uh J, Merchant TE, Li Y, Li X, Sabin ND, Indelicato DJ, Ogg RJ, Boop FA, Jane JA Jr, Hua C (2015) Effects of surgery and proton therapy on cerebral white matter of craniopharyngioma patients. Int J Radiat Oncol Biol Phys 93(1):64–71. https://doi.org/10.1016/j.ijrobp.2015.05.017
Armoogum KS, Thorp N (2015) Dosimetric comparison and potential for improved clinical outcomes of paediatric CNS patients treated with protons or IMRT. Cancers 7(2):706–722. https://doi.org/10.3390/cancers7020706
Boehling NS, Grosshans DR, Bluett JB, Palmer MT, Song X, Amos RA, Sahoo N, Meyer JJ, Mahajan A, Woo SY (2012) Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas. Int J Radiat Oncol Biol Phys 82(2):643–652. https://doi.org/10.1016/j.ijrobp.2010.11.027
Steinbok P, Hukin J (2010) Intracystic treatments for craniopharyngioma. Neurosurg Focus 28(4):E13. https://doi.org/10.3171/2010.1.focus09315
Asl RG, Parach AA, Nasseri S, Momennezhad M, Zakavi SR, Sadoughi HR (2017) Specific absorbed fractions of internal photon and electron emitters in a human voxel-based phantom: a Monte Carlo study. World J Nucl Med 16(2):114–121. https://doi.org/10.4103/1450-1147.203065
Denis-Bacelar AM, Romanchikova M, Chittenden S, Saran FH, Mandeville H, Du Y, Flux GD (2013) Patient-specific dosimetry for intracavitary 32P-chromic phosphate colloid therapy of cystic brain tumours. Eur J Nucl Med Mol Imaging 40(10):1532–1541. https://doi.org/10.1007/s00259-013-2451-6
Ghahraman Asl R, Nasseri S, Parach AA, Zakavi SR, Momennezhad M, Davenport D (2015) Monte Carlo and experimental internal radionuclide dosimetry in RANDO head phantom. Australas Phys Eng Sci Med 38(3):465–472. https://doi.org/10.1007/s13246-015-0367-0
Momennezhad M, Nasseri S, Zakavi SR, Parach AA, Ghorbani M, Asl RG (2016) A 3D Monte Carlo method for estimation of patient-specific internal organs absorbed dose for (99 m)Tc-hynic-Tyr(3)-octreotide Imaging. World J Nucl Med 15(2):114–123. https://doi.org/10.4103/1450-1147.174700
Acknowledgements
We would like to express our gratitude and appreciation to the staff of the Neurosurgery Department of Shohada-e-Tajrish Hospital and the Novin Medical Center for their cooperation in this project.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of national research committee as well as the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Both patients were approved by the local ethics committee at Shohada-e-Tajrish Hospital and Shahid Beheshti University of Medical Sciences.
Informed consent
For this type of study, formal consent is not required but written consent was received from both patients.
Rights and permissions
About this article
Cite this article
Babaei, M., Ghahramani-Asl, R., Sadoughi, HR. et al. Evaluation of Bremsstrahlung radiation dose in stereotactically radiocolloid therapy of cystic craniopharyngioma tumors with 32P radio-colloid. Australas Phys Eng Sci Med 41, 697–711 (2018). https://doi.org/10.1007/s13246-018-0665-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13246-018-0665-4